Skandinaviska Enskilda Banken AB (publ) - INSYS THERAPEUTICS INC NEW ownership

INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 118 filers reported holding INSYS THERAPEUTICS INC NEW in Q1 2017. The put-call ratio across all filers is 1.33 and the average weighting 0.0%.

Quarter-by-quarter ownership
Skandinaviska Enskilda Banken AB (publ) ownership history of INSYS THERAPEUTICS INC NEW
ValueSharesWeighting
Q2 2017$1,107,000
-82.6%
87,500
-85.6%
0.01%
-63.3%
Q1 2017$6,376,000
+80.1%
606,600
+57.6%
0.03%
-30.2%
Q4 2016$3,540,000
-2.4%
384,800
+25.1%
0.04%
+10.3%
Q3 2016$3,628,000
-16.0%
307,700
-7.8%
0.04%
-18.8%
Q2 2016$4,318,000
+0.9%
333,700
+24.7%
0.05%0.0%
Q1 2016$4,281,000
-26.2%
267,700
+35.5%
0.05%
-36.0%
Q4 2015$5,803,000197,5000.08%
Other shareholders
INSYS THERAPEUTICS INC NEW shareholders Q1 2017
NameSharesValueWeighting ↓
Orbimed Advisors 6,171,440$54,802,0000.52%
Regal Investment Advisors LLC 161,600$1,435,0000.34%
Folger Hill Asset Management LP 396,315$3,519,0000.30%
SCHNEIDER CAPITAL MANAGEMENT CORP 181,900$1,615,0000.29%
Mirae Asset Global Investments Co., Ltd. 1,033,683$9,179,0000.17%
JW Asset Management, LLC 29,409$72,0000.05%
TCI Wealth Advisors, Inc. 9,516$85,0000.04%
GAM Holding AG 83,940$745,0000.03%
Freedom Investment Management, Inc. 63,032$560,0000.03%
Sterling Investment Advisors, Ltd. 5,000$44,0000.03%
View complete list of INSYS THERAPEUTICS INC NEW shareholders